{
    "clinical_study": {
        "@rank": "40352", 
        "acronym": "POST-STEMI", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in control group will receive current standard therapy for STEMI: manual thrombus aspiration + Promus Element stent implantation ( with a pressure less than 12 atm), but not post-dilatation"
            }, 
            {
                "arm_group_label": "Post-dilatation", 
                "arm_group_type": "Experimental", 
                "description": "Patients in this group will receive high pressure post-dilatation with a Quantum Maverick balloon after manual thrombus aspiration + Promus Element stent implantation"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effective and safety of post-dilatation in patients with acute ST segment\n      elevated myocardial infarction undergoing primary percutaneous intervention after thrombus\n      aspiration  assessed  by  optical coherence tomography to examine stent Incomplete\n      apposition and strut coverage in patients treated with drug-eluting stents ."
        }, 
        "brief_title": "POST-dilatation to Improve Outcomes in Acute STEMI Patients Undergoing Primary With OCT Assessment", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Clinical Inclusion Criteria:\n\n          -  Age \u226518 years\n\n          -  STEMI >20 mins and <12 hours in duration\n\n          -  ST-segment elevation of \u22651 mm in \u22652 contiguous leads; or Presumably new left bundle\n             branch block; or True posterior MI with ST depression of \u22651 mm in \u22652 contiguous\n             anterior leads\n\n          -  Written, informed consent\n\n        Angiographic Inclusion Criteria\n\n          -  The presence of least 1 acute infarct artery target vessel* in which:\n\n               1. ALL significant lesions are eligible for stenting with study stents, and\n\n               2. ALL such lesions have a visually estimated reference diameter \u22652.5 mm and \u22644.0\n                  mm\n\n               3. All culprit lesion TIMI Flow \u2264  0 or 1 Grade prior to guide wire crossing\n\n          -  Expected ability to deliver the stent(s) to all culprit lesions (absence of excessive\n             proximal tortuosity or severe calcification)\n\n          -  Expected ability to fully expand the stent(s) at all culprit lesions (absence of\n             marked calcification)\n\n        Clinical Exclusion Criteria:\n\n          -  Contraindication to any of the study medications\n\n          -  Patients with cardiogenic shock\n\n          -  History of bleeding diathesis or known coagulopathy , or will refuse blood\n             transfusions\n\n          -  History of intracerebral mass, aneurysm, AVM, or hemorrhagic stroke; stroke or TIA\n             within 6 months or any permanent neurologic deficit; GI or GU bleed within 2 months,\n             or major surgery within 6 weeks; recent or known platelet count <100,000 cells/mm3 or\n             hgb <10 g/dL\n\n          -  Planned elective surgical procedure that would necessitate interruption of\n             thienopyridines during the first 6 months post enrollment\n\n        Angiographic Exclusion Criteria\n\n          -  Bifurcation lesion definitely requiring implantation of stents in both the main\n             vessel + side branch\n\n          -  Infarct related artery is an unprotected left main\n\n          -  >38 mm of study stent length anticipated\n\n          -  Infarction due to stent thrombosis, or infarct lesion at the site of a previously\n             implanted stent\n\n          -  High likelihood of CABG within 30 days anticipated\n\n          -  The culprit lesion will be judged unsuitable for OCT procedure, because of conditions\n             such as left main trunk disease or shock vital"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02121223", 
            "org_study_id": "SAHZJU CT002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Post-dilatation", 
                "description": "post-dilatation with a Quantum Maverick balloon at high pressure (>=16atm) for at least 15 seconds.", 
                "intervention_name": "post-dilatation with a Quantum Maverick balloon", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Control", 
                    "Post-dilatation"
                ], 
                "description": "manual thrombus aspiration followed by Promus Element stent implantation at normal pressure", 
                "intervention_name": "manual thrombus aspiration + Promus Element stent implant", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "acute ST segment elevated myocardial infarction", 
            "primary percutaneous intervention", 
            "Stent Incomplete Apposition"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "drjayj@hotmail.com", 
                "last_name": "Jun Jiang, MD", 
                "phone": "8657187784705"
            }, 
            "facility": {
                "address": {
                    "city": "Hangzhou", 
                    "country": "China", 
                    "state": "Zhejiang", 
                    "zip": "310009"
                }, 
                "name": "Second Affiliated Hospital Zhejiang University School of Medicine"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multi-center,Randomized Controled Trial of POST-dilatation to Improve Outcomes in Acute STEMI Patients Undergoing Primary PCI After Thrombus Aspiration and DES Implantation With OCT Assessment", 
        "overall_contact": {
            "email": "drjayj@hotmail.com", 
            "last_name": "Jun Jiang, MD", 
            "phone": "8657187784705"
        }, 
        "overall_official": {
            "affiliation": "Second Affiliated Hospital Zhejiang University School of Medicine", 
            "last_name": "Jianan Wang, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of Incomplete Stent Apposition (ISA) in OCT at 7 month", 
            "safety_issue": "Yes", 
            "time_frame": "7 months after primary PCI"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02121223"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Second Affiliated Hospital, School of Medicine, Zhejiang University", 
            "investigator_full_name": "Jian'an Wang,MD,PhD", 
            "investigator_title": "Professor, Chief of Heart Center, and President of the Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Final TIMI flow grade 3", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after primary PCI procedure (up to 2 min)"
            }, 
            {
                "measure": "Final TIMI blush Grade 3", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after primary PCI procedure (up to 2 min)"
            }, 
            {
                "measure": "Rate of ST resolution 70% at 30 day", 
                "safety_issue": "Yes", 
                "time_frame": "30 days after primary PCI"
            }, 
            {
                "measure": "Rate of strut coverage in OCT at 7 month", 
                "safety_issue": "Yes", 
                "time_frame": "7 months after primary PCI"
            }, 
            {
                "measure": "MACE at 7 month and 12 month", 
                "safety_issue": "Yes", 
                "time_frame": "7 months and 12 months after primary PCI"
            }, 
            {
                "measure": "TLR ,TLF  at 7 month and 12 month", 
                "safety_issue": "Yes", 
                "time_frame": "7 months and 12months after primary PCI"
            }, 
            {
                "measure": "Stent thrombus rate at  30 day,7 month and 12 month", 
                "safety_issue": "Yes", 
                "time_frame": "30 days, 7 months and 12 months after primary PCI"
            }, 
            {
                "measure": "In-stent and in-segment late loss", 
                "safety_issue": "No", 
                "time_frame": "7 months after primary PCI"
            }
        ], 
        "source": "Second Affiliated Hospital, School of Medicine, Zhejiang University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "The First Hospital of Nanjing Medical University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Shanghai East Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ningbo First Hopital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Second Affiliated Hospital, School of Medicine, Zhejiang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}